Novartis Sues Apotex Over Planned Zometa Generic
Novartis Pharmaceuticals Corp. on Friday filed a patent infringement lawsuit in New Jersey federal court accusing Apotex Inc. of infringing its patent for the cancer drug Zometa by trying to manufacture...To view the full article, register now.
Already a subscriber? Click here to view full article